Wilex AG
Jun 01, 03
14:24 ET
Anti-CEA Monoclonal Antibody Combined With Chemotherapy Demonstrates Positive Preclinical Results in Colon and Breast Cancers
Mar 18, 02
12:28 ET
Wilex Reports Positive Phase Ia Clinical Data on its Anti-Metastatic Urokinase Inhibitor WX-UK1
Jan 14, 02
12:59 ET
4SC and Wilex Sign Cancer Research Collaboration To Optimize Second Generation uPA Inhibitors
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2005 PR Newswire Association LLC. ALL Rights Reserved.
A
United Business Media
company.